What is the Share Price of Syncom Formulations (India) Ltd?

Syncom Formulations (India) Ltd share price is ₹21.61 As on 12 October, 2024|06:16

Home
>
Stocks
>
Syncom Formulations (India) Ltd

Syncom Formulations (India) Ltd

Q: What is the Market Cap of Syncom Formulations (India) Ltd?

The Market Cap of Syncom Formulations (India) Ltd is ₹2,031 As on 12 October, 2024|06:16

Q: What is PE Ratio of Syncom Formulations (India) Ltd?

The P/E ratio of Syncom Formulations (India) Ltd is 23.1 As on 12 October, 2024|06:16

Q: What is PB Ratio of Syncom Formulations (India) Ltd?

The PB ratio of Syncom Formulations (India) Ltd is 14.50 As on 12 October, 2024|06:16

₹ 21.61 -0.43 (-1.95%)
Updated on 11-10-2024 4:40 PM

Stock Rating

Pros 1

Cons 8

Price Performance

Day's Low
₹21.37

Day's High
₹22.08

₹ 21.61

52-w low
₹7.25

52-w high
₹27.9

21.61

Day's open
₹22.08
Previous close
₹22.040001
VWAP
₹21.74
Lower price band
₹19.83
Upper price band
₹24.24

Today's Market Action

The last traded share price of Syncom Formulations (India) Ltd was 21.61 down by -1.95% on the NSE. Its last traded stock price on BSE was 21.63 down by -1.86%. The total volume of shares on NSE and BSE combined was 3,151,377 shares. Its total combined turnover was Rs 6.85 crores.

Medium and Long Term Market Action

Syncom Formulations (India) Ltd hit a 52-week high of 27.9 on 10-09-2024 and a 52-week low of 7.25 on 25-10-2023. The stock price of Syncom Formulations (India) Ltd is down by -17% over the last one month. It is up by 134.89% over the last one year. Don't forget to check the full stock price history in the table below.

Fundamentals

Market Cap (Cr): 2031
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About

Data not available.

FAQ's

What is Share Price of Syncom Formulations (India) Ltd?

What is the Market Cap of Syncom Formulations (India) Ltd?

What is PE Ratio of Syncom Formulations (India) Ltd?

What is PB Ratio of Syncom Formulations (India) Ltd?

What is the CAGR of Syncom Formulations (India) Ltd?

How to Buy Syncom Formulations (India) Ltd Share?

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

Pros

Momentum Strength
The stock is currently exhibiting strong momentum, & is showing consistent strong relative strength.

Cons

Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Poor Cash Flow Conversion
The business has very poor cash conversion ratio of only -14.29% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
Low Interest Coverage
The company has a very low Interest coverage ratio of 5.60 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Low Pricing Power & High Competition
The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
Poor Working Capital Cycle
The company has a very poor working capital cycle of 169 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
Poor Corporate Governance
The general corporate governance standards of the company are poor which can negatively impact shareholder value and returns.

Valuation Analysis

Margin of safety
(12/10/2024)

107

Margin of Safety Index: Very High

86.79%

86.79% People are bullish about Syncom Formulations (India) Ltd

13.21%

13.21 % People are bearish about Syncom Formulations (India) Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %